Exchange: NASDAQ·Updated 07:34 PM EDT
News
all
press releases
Bernstein upgrades Sartorius to “outperform” on margin recovery, pharma demand
investing.com
RBC upgrades Sartorius stocks as recent pullback ’provides entry opportunity’ 
investing.com
Sartorius AG and its biotech subsidiary lifted to Buy at Barclays
Investing.com -- Barclays has upgraded Sartorius AG (F:SATG) and its subsidiary Sartorius Stedim (EPA:STDM) Biotech SA (VIE:DIM) to Overweight, citing a shift in the bioprocessing industry toward a post-COVID recovery.
investing.com
Sartorius shares soar 11% on strong Q4, order intake drives rally
investing.com

Advertisement|Remove ads.